The European Pharmacovigilance Risk Assessment Committee reviewed reported cases and post-marketing safety data to evaluate the risks of PRES and RCVS with pseudoephedrine-containing medicines.
In addition to failure to maintain appropriate boundaries, Dr. Jeffrey Martin Steinberg was also found to have inappropriately withheld prescriptions for patients.